September's Paper of the Month looks at a double-blind, randomised, placebo-controlled trial involving patients with stage I, II, or III rectal cancer or stage II or III colon cancer with somatic alterations in PI3K pathway genes.
This month's paper assessed the noninferior results of chemoradiotherapy and local excision compared with Total Mesorectal Excision in T2-T3ab, N0, M0 Rectal Cancer.
At this year’s ACPGBI Annual Meeting, many from the colorectal community gathered to honour the remarkable legacy of Professor Neil Smart. His dedication to colorectal surgery, unwavering kindness and commitment to patients will always be remembered.